Stocks
24234CPNO
YHDHealthcarePharmaceuticals
A specialty pharmaceutical company focused on developing and commercializing treatments for central nervous system disorders, including schizophrenia and bipolar disorder. Its lead product, Caplyta, has driven revenue growth and attracted investor attention due to its differentiated mechanism of action. The company continues to expand its pipeline and pursue regulatory approvals for additional indications.
Congressional Interest in 24234 (CPNO)
1 member of Congress has disclosed 1 trade in 24234 (CPNO), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CPNO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2013-05-01 | John Hoeven | buy | $15K-$50K |